Saliva Collection Devices Diagnostics Market Share

Global Saliva Collection & Diagnostics Market Overview

Saliva Collection and Diagnostic Market Size was valued at USD 3.49 Billion in 2023. The Saliva Collection and Diagnostic industry is projected to grow from USD 3.67 Billion in 2024 to USD 6.56 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 11.34% during the forecast period (2024 - 2032). Increasing demand for rapid diagnosis of chronic diseases, advancements in infant saliva collection techniques, and growing awareness for simple and safe diagnosis of various diseases are the key market drivers for saliva collection & diagnostics enhancing the market growth.

Site of Collection: Secondary Research, Primary Research, MRFR Database and Analyst Review

Saliva Collection & Diagnostics Market Trends

• Growing Prevalence of spine degeneration to boost market growth

The saliva collection and diagnostics market industry has grown tremendously over the past few years. Saliva plays an important role in the diagnosis of different diseases. In the early days, most diagnoses were painful and expensive blood tests, which were later replaced by more convenient options for saliva testing and diagnosis. Advances in the industry and field of saliva collection and diagnostics are supported by numerous publications that support various new applications of saliva. There are three methods of stimulating saliva volume collection: no stimulation, mechanical and acid stimulation. These are the factors which enhance the saliva collection & diagnostics market CAGR across the globe in the recent years.

The saliva-based test is painless and precise. These tests are reliable ways to assess hormone levels in women. Over the past few years, blood tests have been used to measure female hormone levels. However, blood sampling is expensive, invasive and difficult to perform. Consequently, a major shift towards the adoption of cheaper and more convenient sample types has been witnessed. Saliva-based diagnostics are used to measure a variety of physiological conditions such as stress, depression, and sleep disturbances. These tests are also used in occupational health and sports medicine. These factors are driving the growth of saliva collection & diagnostics market revenue.

Saliva Collection & Diagnostics Market Segment Insights

Saliva Collection & Diagnostics Site of Collection Insights

The market of Saliva Collection & Diagnostics is segmented based on Site of Collection, parotid gland collection, submandibular/sublingual gland collection, and minor salivary glands collection.  The submandibular/sublingual gland harvesting segment garnered the highest saliva collection & diagnostics market revenue in 2021 and is expected to continue to dominate during the forecast period. The most common disorder affecting the salivary glands in middle-aged adults is called salivary gland stones or salivary stones. Approximately 80% of salivary gland stones occur in the submandibular gland, followed by the parotid gland at 6-15%, and the minor or sublingual salivary glands at 2%. Rising cases of sialic acid stones is likely to boost the market growth for saliva collection & diagnostics in the coming years.

Figure 2:  Saliva Collection & Diagnostics Market, by Site of Collection, 2023 & 2032 (USD billion)

Site of Collection: Secondary Research, Primary Research, MRFR Database and Analyst Review

Saliva Collection & Diagnostics Application Insights

The Saliva Collection & Diagnostics market segmentation into research, disease diagnostics, and forensic applications. In the market, the disease diagnostics segment is expected to account for the largest revenue share in 2022 owing to the rising incidence of the disease globally and the corresponding increase in the need for appropriate diagnostic strategies. The research sector is expected to experience considerable expansion in the coming years owing to increasing investments by public and private market players as well as government in the R&D sector. These factors boost the market growth of saliva collection & diagnostics.

September 2022: Australian researchers at the Yale School of Public Health claim a saliva-based test is effective in detecting SARS-CoV-2. Similarly, researchers at Ahmedabad University discovered miRNAs in human saliva samples in October 2022. This finding shows promising results in predicting oral cancer prognosis.

Saliva Collection & Diagnostics End User Insights

The End User-based Saliva Collection & Diagnostics market data includes hospitals & dental clinics, diagnostic centers, and investigation laboratories. Diagnostic laboratories segment by application is expected to drive market growth owing to the increasing use of saliva collection and diagnostics among laboratories. Factors contributing to the growth of the segment include the prevalence of infectious and chronic diseases; ease of conduct; increasing number of independent diagnostic laboratories as well as built-in diagnostic laboratories within healthcare institutions; and availability of skilled professionals.

February 2021: Eurofins Scientific has introduced an ultra-fast extraction-free RT-PCR technique for saliva samples and throat rinse matrices.

Saliva Collection & Diagnostics Regional Insights

By Region, the study provides the market insights for saliva collection & diagnostics into North America, Europe, Asia-Pacific and Rest of the World. North America dominates the saliva testing devices market due to having the necessary funding to conduct research and develop new effective treatments through clinical trials. Furthermore, adoption of technologically advanced products and increasing number of regulatory agencies are driving the saliva collection devices market in North America to be the most lucrative. Asia Pacific is expected to witness the largest market growth during the forecast period owing to rising awareness about easy and safe diagnosis of various diseases through several seminars and conferences held in the region.

Further, the major countries studied in the market report for saliva collection & diagnostics are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3:  SALIVA COLLECTION & DIAGNOSTICS MARKET SHARE BY REGION 2022 (%)

Site of Collection: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe market of saliva collection & diagnostics accounts for the second-largest market share due to the regional market is segmented into Eastern Europe and Western Europe. The Western European market for saliva collection and diagnostics is segmented into the United Kingdom, Germany, France, Italy, Spain, and Rest of Europe. Government initiatives along with high number of people suffering from cancer are driving the market growth for saliva collection and diagnostics. Moreover, The German market of saliva collection & diagnostics holds the largest market share, and the UK market of saliva collection & diagnostics is the fastest growing market in the European region.

The Asia Pacific market of Saliva Collection & Diagnostics is expected to grow at the fastest CAGR from 2024 to 2032. The Asia Pacific region is expected to witness the fastest growth rate owing to significant advancements in the field of diagnostic testing. According to a new study published in April 2022, India is witnessing the widespread adoption of home diagnostic tests and this trend is expected to increase in the coming years. People are adopting home-based diagnostic testing because it provides quick results at a lower cost. These factors are driving the demand for saliva testing in the region. Furthermore, the China market of saliva collection & diagnostics holds the largest market share and Japan market of saliva collection & diagnostics is the fastest growing market in the region.

Saliva Collection & Diagnostics Key Market Players & Competitive Insights

Major market players are investing heavily in research and development to increase their product lines, which will help the Saliva Collection & Diagnostics market to grow further. The market players have also undertaken a number of strategic initiatives to expand their footprints, including key market developments such as new product launches, contractual agreements, mergers and acquisitions, increasing investments, and collaborations with other organizations. Competitors in the Saliva Collection & Diagnostics industry must offer cost-effective products to expand and survive in the increasingly competitive and rising market environment.

One of the key business strategies adopted by the manufacturers in the Saliva Collection & Diagnostics industry to benefit their customers and expand their market segment is to manufacture locally to reduce operating costs. In recent years, the Saliva Collection & Diagnostics industry has provided some of the most significant benefits to medicine. Major players in the Saliva Collection & Diagnostics market such as Neogen Corporation. (US), SARSTEDT AG & Co. KG (Germany), Quest Diagnostics (US), OraSure Technologies (US) and Abbott Laboratories (US) are focusing on expanding the market demand by investing in research and development activities.

Headquartered in Michigan, USA, Neogen was founded in 1982. The company provides a broad range of solutions and services to the food processing, animal protein and agriculture industries, as well as the life sciences and toxicology sectors. The company has two business divisions, food safety and animal safety, of which animal safety is the market-focused department. The company offers products in categories such as animal safety, food safety, genomics, life sciences and toxicology, with toxicology being a category of market focus. The company is committed to the continuous development of saliva testing equipment. In January 2020, NEOGEN Corporation announced that it had acquired Productos Quimicos Magiar, a distributor of the company's food safety diagnostic products, which will increase future sales and revenue.

Also, OraSure Technologies, Inc., headquartered in Pennsylvania, USA, develops, manufactures and distributes rapid diagnostic tests, sample collection and stabilization devices, and molecular service solutions designed to detect critical medical conditions. The company has two business segments, Diagnostics and Molecular Solutions, with Diagnostics being the market-focused segment. The company is engaged in the provision of products in categories such as diagnostics and test sampling tools, of which diagnostics and testing is the category that the market is focusing on. The company has initiated several strategic initiatives to expand its market. In January 2021, DNA Genotek, a subsidiary of OraSure Technologies, Inc., announced that its product, named OMNIgene ORAL (OM-505) saliva collection kit, had been granted Emergency Use Authorization (EUA) to Ambry Genetics for Ambry COVID- 19 RT-PCR saliva test. This EUA grant received by the company increases its future sales and revenue.

Key Companies in the Saliva Collection & Diagnostics market includes

• Neogen Corporation (US).


• SARSTEDT AG & Co. KG (Germany)


• Quest Diagnostics (US)


• OraSure Technologies (US)


• Abbott Laboratories (US), among others

Saliva Collection & Diagnostics Industry Developments

August 2022 LordsMed has entered into an exclusive partnership with Singapore-based diagnostic kit manufacturer Sensing Self to bring the world's first COVID-19 saliva-based rapid antigen test kit to India.

January 2022 Eurobio Scientific has an exclusive distribution contract with Orasure for the commercialization of the saliva self-test OraQuick. This exclusive contract covers the French market and its overseas territories.

December 2021 F. Hoffmann-La Roche Ltd announces the acquisition of the CE mark for the Cobas SARS-CoV-2 Qualitative Test using samples on the company's Cobas 6800/8800 systems.

January 2020 DNA Genotek has announced FDA general use clearance for products in the Oragene family. Oragene Dx products are used for non-invasive saliva sample collection for in vitro diagnostic testing of human DNA.